全文获取类型
收费全文 | 3758篇 |
免费 | 159篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 66篇 |
妇产科学 | 26篇 |
基础医学 | 355篇 |
口腔科学 | 61篇 |
临床医学 | 238篇 |
内科学 | 933篇 |
皮肤病学 | 32篇 |
神经病学 | 509篇 |
特种医学 | 236篇 |
外科学 | 666篇 |
综合类 | 29篇 |
预防医学 | 88篇 |
眼科学 | 89篇 |
药学 | 227篇 |
中国医学 | 6篇 |
肿瘤学 | 361篇 |
出版年
2023年 | 17篇 |
2022年 | 45篇 |
2021年 | 64篇 |
2020年 | 52篇 |
2019年 | 59篇 |
2018年 | 62篇 |
2017年 | 55篇 |
2016年 | 67篇 |
2015年 | 65篇 |
2014年 | 90篇 |
2013年 | 114篇 |
2012年 | 227篇 |
2011年 | 238篇 |
2010年 | 138篇 |
2009年 | 110篇 |
2008年 | 200篇 |
2007年 | 249篇 |
2006年 | 208篇 |
2005年 | 208篇 |
2004年 | 172篇 |
2003年 | 250篇 |
2002年 | 230篇 |
2001年 | 103篇 |
2000年 | 84篇 |
1999年 | 106篇 |
1998年 | 61篇 |
1997年 | 42篇 |
1996年 | 36篇 |
1995年 | 31篇 |
1994年 | 36篇 |
1993年 | 27篇 |
1992年 | 55篇 |
1991年 | 51篇 |
1990年 | 39篇 |
1989年 | 38篇 |
1988年 | 26篇 |
1987年 | 17篇 |
1986年 | 31篇 |
1985年 | 44篇 |
1984年 | 34篇 |
1983年 | 23篇 |
1982年 | 18篇 |
1981年 | 11篇 |
1980年 | 18篇 |
1979年 | 8篇 |
1978年 | 8篇 |
1974年 | 8篇 |
1971年 | 7篇 |
1970年 | 7篇 |
1968年 | 7篇 |
排序方式: 共有3943条查询结果,搜索用时 2 毫秒
41.
Kaji T Kuge Y Yokota C Tagaya M Inoue H Shiga T Minematsu K Tamaki N 《European journal of nuclear medicine and molecular imaging》2004,31(1):64-70
Iodine-123 labelled iomazenil ([123I]IMZ) has been reported to be a useful marker of neuronal viability. The brain distribution of [123I]IMZ, however, has not been correlated with the pathophysiological response in detail after an ischaemic insult. To characterise [123I]IMZ as a marker of neuronal viability, we compared its brain distribution with cyclooxygenase-2 (COX-2) expression, DNA fragmentation and cellular integrity. [123I]IMZ and [125I]IMP were injected into rats with focal cerebral ischaemia for the purpose of dual-tracer autoradiography. COX-2 and microtubule-associated protein-2 (MAP-2, a marker of cellular integrity) were immunostained. In situ DNA polymerase-I-dependent dUTP incorporation into damaged DNA was used as an indicator of DNA fragmentation. Lesion to normal ratios (LNRs) for [123I]IMP and [125I]IMZ were calculated. [123I]IMZ accumulation was preserved in several regions with impaired [123I]IMP accumulation. COX-2 expression was occasionally observed, whereas neither DNA fragmentation nor MAP-2 denaturation was detected in these regions. DNA fragmentation and impaired MAP-2 immunostaining were observed only in the regions with reduced LNRs for both tracers. The LNR for [123I]IMZ was significantly lower in regions with impaired MAP-2 immunostaining (0.120±0.152, P<0.0001), in regions positive for dUTP incorporation (0.488±0.166, P<0.0001) and in regions positive for COX-2 expression (0.626±0.186, P<0.001) than in histologically normal regions (0.784±0.213). Thus, neuronal DNA is still intact and cellular integrity is maintained in the ischaemic regions with preserved [123I]IMZ accumulation. The impairment of [123I]IMZ accumulation precedes DNA fragmentation and denaturation of cellular integrity. These results provide the molecular basis of [123I]IMZ distribution. 相似文献
42.
Osoegawa M Niino M Tanaka M Kikuchi S Murai H Fukazawa T Minohara M Miyagishi R Taniwaki T Tashiro K Kira J 《Internal medicine (Tokyo, Japan)》2005,44(9):934-938
We evaluated the clinical courses of 216 patients with multiple sclerosis (MS) diagnosed according to the recommended diagnostic criteria of McDonald et al (10). Sixty-five patients clinically displaying selective involvement of the optic nerves and spinal cord were classified as opticospinal MS (OS-MS), while the other 151 showing disseminated involvement of the central nervous system were classified as conventional MS (C-MS). The disease duration did not differ significantly between the two subtypes (11.2 years vs. 11.5 years). In addition to a higher age of onset, female preponderance and higher Kurtzke's expanded disability status scale (EDSS) scores, the OS-MS patients showed a markedly lower frequency of secondary progressive MS than the C-MS patients (4.6% vs. 29.1%, p=0.0001). The EDSS scores of the C-MS patients were significantly correlated with the disease duration, while those of the OS-MS patients were not. Among the C-MS patients, the frequency of secondary progressive MS was significantly more common in patients with a disease duration of more than 10 years than in those with a shorter duration. These results suggest that the irreversible disability in OS-MS is determined by relapses, rather than by chronic progression, whereas C-MS has a similar clinical course to MS in Westerners. 相似文献
43.
Yasuhiro Miyake Masaharu Ando Eisuke Kaji Tatsuya Toyokawa Morihito Nakatsu Mamoru Hirohata 《Hepatology research》2008,38(10):980-986
Aim: A low platelet count leads to dose reduction of interferon (IFN) and is associated with failure to achieve a sustained virological response (SVR) in chronic hepatitis C patients. However, partial splenic embolization (PSE) is effective for treating thrombocytopenia resulting from hypersplenism. Methods: We compared the clinical features of 10 patients receiving PSE prior to the combination therapy of IFN and ribavirin (RBV) (PSE group) with those of 10 non‐receiving PSE patients (non‐PSE group). Results: In all 10 patients, PSE was successfully performed without serious adverse events. After PSE, leukocyte, neutrophil, and platelet counts significantly increased. The period from PSE to the initiation of the combination therapy was 15 (7–21) days. In the PSE group, two of six patients (33%) infected with genotype 1, and all four patients infected with genotype 2, achieved SVR. In the non‐PSE group, only three patients infected with genotype 2 achieved SVR. Two patients in the PSE group and one in the non‐PSE group discontinued the combination therapy. Three patients of the PSE group and five of the non‐PSE group reduced the dose of pegylated IFN‐α‐2b because of thrombocytopenia. In the PSE group, platelet counts during the combination therapy fell to baseline levels; however, they did not fall to lower levels than baseline levels. In the non‐PSE group, platelet counts 1 month after the initiation of the therapy were lower than baseline levels. Conclusion: The increase of platelet counts after PSE may allow the safe use of IFN and RBV and improve the SVR rate in chronic hepatitis C patients with thrombocytopenia. 相似文献
44.
We report a rare case of a patient in whom severe subcutaneous and mediastinal emphysema occurred in association with summer-type hypersensitivity pneumonitis and in whom overdistention or disruption of alveoli with obliteration of the respiratory bronchioles was revealed on open lung biopsy. This case suggests that obstructive bronchiolitis with hypersensitivity pneumonitis is an etiologic factor of mediastinal emphysema. 相似文献
45.
A prospective clinical study of theophylline safety in 3810 elderly with asthma or COPD 总被引:3,自引:0,他引:3
Ohta K Fukuchi Y Grouse L Mizutani R Rabe KF Rennard SI Zhong NS 《Respiratory medicine》2004,98(10):1016-1024
A large-scale prospective study was conducted in 3810 Japanese elderly (> or =65 years old) patients with asthma or chronic obstructive pulmonary disease (COPD) who had been treated with sustained-release theophylline tablets (THEODUR) at a dose of 400 mg/day for 1-6 months, in principle. Among 3798 protocol-complying patients (mean age: 73.8 +/- 0.10 years, 1997 with COPD), 261 theophylline-related adverse events were observed in 179 (4.71%) patients. The 5 most frequently observed adverse events were "nausea" (40 episodes, 1.05%), "loss of appetite" (22 episodes, 0.56%), "hyperuricemia" (16 episodes, 0.42%), "palpitation" (15 episodes, 0.39%), and "increased alkaline phosphatase" (11 episodes, 0.28%). No convulsions were reported. Six patients had serious adverse events. The incidence of theophylline-related adverse events was higher in patients with hepatic disease (odds ratio: 1:1.81) and in patients with arrhythmia (odds ratio: 1:1.88). Blood drug concentration measurements in 736 patients indicated that the drug levels were < or =15 microg/ml in 641 patients (87.1%), and no correlation was noted between dose and theophylline-related adverse events. These results suggest that sustained-release theophylline can be used safely in elderly patients with asthma or COPD. 相似文献
46.
Human pancreatic growth hormone-releasing factor stimulates release of growth hormone in conscious unrestrained male rabbits 总被引:1,自引:0,他引:1
The effect on GH secretion of GH-releasing factor (GRF), a 44-amino acid peptide recently isolated from a human pancreatic tumor (hpGRF), was examined in conscious male rabbits. During a 6-h period (1030-1630 h) of the control study individual rabbits exhibited pulsatile GH release with a surge at 1030-1200 h, a trough at 1200-1400 h, and a second peak at 1400-1630 h. Intravenous bolus injections of 1 and 10 micrograms hpGRF caused significant and dose-related increases in plasma GH during both the period of the trough (1300 h) and the surge (1530 h), although the GH responses were obviously higher during the latter than the former period. Passive immunization with anti-somatostatin (SRIF) sheep serum resulted in a prompt increase in plasma GH immediately after an injection of the antiserum. When 0.1, 1, and 10 micrograms hpGRF were successively injected iv at 1215, 1345, and 1515 h, respectively, maximum levels of plasma GH after hpGRF in anti-SRIF sheep serum-treated rabbits were significantly higher than in animals given normal sheep serum. The plasma GH responses to 10 micrograms hpGRF, given iv only once at 1515 h in normal sheep serum-treated animals, were not different from those to 10 micrograms hpGRF injected at 1515 h after the prior administration either of the smaller hpGRF dose (0.1 micrograms, 1215 h; 1 microgram, 1345 h), nor of the large dose (10 micrograms, 1100 h). These findings suggest the following: 1) that the secretion of GH is pulsatile in conscious, unrestrained male rabbits; 2) that hpGRF is a potent secretagogue for GH release in rabbits as well as other species; 3) that the magnitude of plasma GH response to hpGRF is different according to timing of the injection during the course of pulsatile GH secretion but is not influenced by the prior administration of hpGRF (no priming effect); and 4) that the responsiveness of plasma GH to hpGRF is affected by circulating endogenous SRIF. 相似文献
47.
The Thermosensitive Lesion in the Replication of the Drug Resistance Factor, Rts1 总被引:13,自引:0,他引:13 下载免费PDF全文
C. G. DiJoseph Akira Kaji 《Proceedings of the National Academy of Sciences of the United States of America》1974,71(6):2515-2519
The DNA of the thermosensitive R factor, Rts1, has been examined by the technique of sedimentation in alkaline sucrose density gradients. Rts1 DNA was found as closed covalent circles in only a few copies per cell in an Escherichia coli host at the permissive temperature. Rts1 DNA appears to be synthesized at the nonpermissive temperature, but was not found as closed covalent circles. However, circular DNA could be recovered upon shift down to the permissive temperature. The large number of plasmid-negative cells which accumulate after prolonged culture at non-permissive temperature may be due to a strong selective pressure favoring the growth of rare R(-) segregants. 相似文献
48.
Systemic capillary leak syndrome 总被引:2,自引:0,他引:2
Kawabe S Saeki T Yamazaki H Nagai M Aoyagi R Miyamura S 《Internal medicine (Tokyo, Japan)》2002,41(3):211-215
A 40-year-old woman was referred to our hospital with severe hypovolemic shock and anasarca. The laboratory findings showed marked hemoconcentration and a decrease in total serum protein with the presence of monoclonal IgG-lambda. She had had a similar episode of generalized edema 2 years previously. We diagnosed the patient as having typical systemic capillary leak syndrome (SCLS) and she improved gradually after infusion of albumin-containing fluid. SCLS is a very rare condition caused by unexplained episodic capillary hyperpermeability. Its treatment has remained largely supportive and the prognosis is generally poor. Awareness of SCLS is necessary for improvement of the outcome. 相似文献
49.
50.
Taniguchi M Nakano H Kuwahara K Masuda I Okawa Y Miyazaki H Okoshi H Kaji M Noguchi Y Asukata I 《Internal medicine (Tokyo, Japan)》2003,42(1):21-24
OBJECTIVE: The purpose of this study was to evaluate the prognostic and clinical significance of newly acquired complete right bundle branch block (CRBBB) in airline pilots. PATIENTS: This study included pilots with acquired CRBBB, identified from a group of over 2,700 Japan Airline pilots. When the pilots applied for employment, a past medical history, physical examination, electrocardiogram, and chest radiograph were obtained. The pilots with ECG abnormality including CRBBB were not included in the study because of hiring requirements. RESULTS: Thirty-six pilots with CRBBB were identified between 1983 and 2002. All pilots with CRBBB were evaluated for the presence of ischemic heart disease by treadmill exercise testing, echocardiogram and exercise thallium scintigraphy. Twelve individuals underwent coronary angiography. The mean age of pilots was 44.4 +/- 5.8 years. The mean observation period was 10.9 +/- 5.7 years. For each of the 36 study subjects, Holter electrocardiogram and echocardiogram were obtained every 6 months after the CRBBB was detected. Exercise stress testing was performed every year. Exercise thallium scintigraphy was performed every 2 years to detect ischemic heart disease. During the observation period, two pilots stopped flying temporarily because of frequent ventricular premature beats and one pilot stopped flying permanentaly because of atrial fibrillation. During the follow-up period, no cardiovascular events were observed in pilots with CRBBB who had no underlying ischemic heart disease. CONCLUSION: Acquired CRBBB does not confer a poor prognosis, particularly in young men working as a pilot if there is no evidence of ischemia on exercise stress testing, echocardiography and exercise thallium scintigraphy. 相似文献